source
- Verdiva Bio appoints former Metsera CMO Steve Marso as it nears key obesity pill readoutsVerdiva Bio, a developer of a long-acting oral obesity treatment, announced the appointment of Steve Marso as its chief medical officer. Marso joins from Metsera, a biotech that pursued similar GL…
- Teladoc expands beyond single-visit model with new service launchTeladoc, a pioneer in virtual care, originally built its platform around brief, one-time doctor appointments that could be completed without an in-person visit. The company now says that this sing…